1-163069317-G-T
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001113381.1(RGS4):c.-168G>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000355 in 1,551,404 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001113381.1 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RGS4 | NM_001113381.1 | c.-168G>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 1 of 4 | NP_001106852.1 | |||
RGS4 | NM_001102445.3 | c.124G>T | p.Gly42Cys | missense_variant | Exon 2 of 6 | NP_001095915.1 | ||
RGS4 | NM_001113381.1 | c.-168G>T | 5_prime_UTR_variant | Exon 1 of 4 | NP_001106852.1 | |||
RGS4 | NM_005613.6 | c.-168G>T | upstream_gene_variant | ENST00000367909.11 | NP_005604.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152052Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000961 AC: 15AN: 156114 AF XY: 0.000109 show subpopulations
GnomAD4 exome AF: 0.0000193 AC: 27AN: 1399234Hom.: 0 Cov.: 33 AF XY: 0.0000217 AC XY: 15AN XY: 690190 show subpopulations
GnomAD4 genome AF: 0.000184 AC: 28AN: 152170Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74370 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.124G>T (p.G42C) alteration is located in exon 2 (coding exon 2) of the RGS4 gene. This alteration results from a G to T substitution at nucleotide position 124, causing the glycine (G) at amino acid position 42 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at